95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.81%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-23.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-256.60%
Negative EBIT growth while AEM is at 1.03%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-256.60%
Negative operating income growth while AEM is at 1.03%. Joel Greenblatt would press for urgent turnaround measures.
-317.43%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-315.38%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-315.38%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.31%
Share count expansion well above AEM's 0.42%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.30%
Diluted share count expanding well above AEM's 0.34%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-7.56%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-8.06%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
205.89%
10Y revenue/share CAGR 1.25-1.5x AEM's 151.44%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
2.32%
Positive 5Y CAGR while AEM is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-12.59%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
176.09%
10Y OCF/share CAGR at 75-90% of AEM's 216.81%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-14.51%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-20.28%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-552.06%
Negative 10Y net income/share CAGR while AEM is at 1397.10%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-257.57%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-302.57%
Negative 3Y CAGR while AEM is 37.93%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
161.66%
10Y equity/share CAGR above 1.5x AEM's 15.22%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
17.18%
Positive 5Y equity/share CAGR while AEM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
3.49%
3Y equity/share CAGR above 1.5x AEM's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
13.77%
Below 50% of AEM's 44.79%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
69.37%
3Y dividend/share CAGR above 1.5x AEM's 45.99%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-27.48%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while AEM stands at 3.04%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.67%
Negative asset growth while AEM invests at 2.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.48%
We have a declining book value while AEM shows 1.30%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-7.41%
We’re deleveraging while AEM stands at 0.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-26.45%
We cut SG&A while AEM invests at 0.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.